RWAY Q1 2026 Earnings EPS Miss Highlights Margin Headwinds Amid Stable Investment Portfolio Kiniksa Pharmaceuticals Q1 2026 Earnings EPS Surprises by 315 Despite Stock Decline Lyell Immunopharma LYEL Q1 2026 Earnings Narrower Loss Beats Estimates as Biotech Advances Pipeline M Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher BELFA Q1 2026 Earnings EPS Surpasses Estimates Stock Rises on Strong Performance PGY Q1 2026 Earnings Massive EPS Beat Shocks Analysts Stock Surges